PUBLISHER: Value Market Research | PRODUCT CODE: 1991537
PUBLISHER: Value Market Research | PRODUCT CODE: 1991537
Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
The Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market size is expected to reach USD 7.81 Billion in 2034 from USD 3.59 Billion (2025) growing at a CAGR of 9.02% during 2026-2034.
The global enzyme-linked immunosorbent assay (ELISA) testing market is experiencing strong growth due to its widespread use in disease diagnosis and biomedical research. ELISA is a laboratory technique used to detect antibodies, antigens, and proteins in biological samples. It is commonly used in the diagnosis of infectious diseases, autoimmune disorders, and cancer biomarkers.
One of the major drivers of the market is the increasing demand for accurate and reliable diagnostic testing. Healthcare providers and research laboratories rely heavily on ELISA tests because they offer high sensitivity and specificity. Additionally, rising investments in biotechnology research and the development of advanced diagnostic technologies are boosting the market.
In the future, the ELISA testing market is expected to grow as demand for rapid and efficient diagnostic solutions increases worldwide. Advances in laboratory automation and multiplex testing technologies are likely to enhance testing efficiency. As global healthcare systems emphasize early disease detection and personalized medicine, ELISA testing will continue to play a crucial role in diagnostics and research.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Test type
- Sandwich ELISA
- Indirect ELISA
- Multiple and Portable ELISA
- Competitive ELISA
By Applications
- Immunology
- Inflammation
- Infectious Diseases
- Cancer
- Protein Quantification
- Others
COMPANIES PROFILED
- Thermo Fisher Scientific Inc, American Laboratory Products Company ALPCO, BD Biosciences, BioRad Laboratories Inc, BioMrieux, OrthoClinical Diagnostics Inc, R D Systems Inc, ZEUS Scientific Inc, Enzo Life Sciences, Inc, Biolegand, Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Test Type
- 4.2. Sandwich ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Indirect ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Multiple and Portable ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Competitive ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY APPLICATIONS 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Applications
- 5.2. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Inflammation Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Protein Quantification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY REGION 2022-2034 (USD MN)
- 6.1. Regional Outlook
- 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 6.2.1 By Test Type
- 6.2.2 By Applications
- 6.2.3 United States
- 6.2.4 Canada
- 6.2.5 Mexico
- 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 6.3.1 By Test Type
- 6.3.2 By Applications
- 6.3.3 United Kingdom
- 6.3.4 France
- 6.3.5 Germany
- 6.3.6 Italy
- 6.3.7 Russia
- 6.3.8 Rest Of Europe
- 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 6.4.1 By Test Type
- 6.4.2 By Applications
- 6.4.3 India
- 6.4.4 Japan
- 6.4.5 South Korea
- 6.4.6 Australia
- 6.4.7 South East Asia
- 6.4.8 Rest Of Asia Pacific
- 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 6.5.1 By Test Type
- 6.5.2 By Applications
- 6.5.3 Brazil
- 6.5.4 Argentina
- 6.5.5 Peru
- 6.5.6 Chile
- 6.5.7 Rest of Latin America
- 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 6.6.1 By Test Type
- 6.6.2 By Applications
- 6.6.3 Saudi Arabia
- 6.6.4 UAE
- 6.6.5 Israel
- 6.6.6 South Africa
- 6.6.7 Rest of the Middle East And Africa
Chapter 7. COMPETITIVE LANDSCAPE
- 7.1. Recent Developments
- 7.2. Company Categorization
- 7.3. Supply Chain & Channel Partners (based on availability)
- 7.4. Market Share & Positioning Analysis (based on availability)
- 7.5. Vendor Landscape (based on availability)
- 7.6. Strategy Mapping
Chapter 8. COMPANY PROFILES OF GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING INDUSTRY
- 8.1. Top Companies Market Share Analysis
- 8.2. Company Profiles
- 8.2.1 Thermo Fisher Scientific. Inc
- 8.2.2 American Laboratory Products Company (ALPCO)
- 8.2.3 BD Biosciences
- 8.2.4 Bio-Rad Laboratories Inc
- 8.2.5 BioMerieux
- 8.2.6 Ortho-Clinical Diagnostics Inc
- 8.2.7 R & D Systems Inc
- 8.2.8 ZEUS Scientific Inc
- 8.2.9 Enzo Life Sciences, Inc
- 8.2.10 Biolegand, Inc
